For example, in a mouse bladder cancer model, the dual inhibition of G9a and DNA methyltransferase (DNMT) enhanced the response to anti-PD-L1 therapy, increased the tumor infiltration of NK cells and CD8+ T cells, and facilitated tumor regression130. This evidence concerns the gene CD8A and urinary bladder carcinoma.